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1. Introduction
   Seborrheic dermatitis (SD) and atopic dermatitis (AD) 
are recurrent and chronic skin diseases that are prevalent 
in society and in different age groups with various forms. 
They have a range of symptoms, from mild to very severe 
and can present a nuisance. However, no proven specific 
cause has been found for them until now. However, 
other causes besides the genetic and environmental 
component, like Pityrosporum ovale fungi may also play 
a role in causing SD. Demodex mites including Demodex 
folliculorum (D. folliculorum) and Demodex brevis live 
within hair follicles and sebaceous glands in the skin[1]. 
Up to now several studies have shown that Demodex 
mites could prompt an inflammatory response in rosacea 
patients[2-5]. Potential role of Demodex mites in SD and 
AD is unclear. Although some studies have suggested 
the influence of these mites on SD, there is no research 
on the association between AD and these mites[6,7]. In 
some studies, Demodex infestation also has increased 
the incidence of rosacea, steroid-dependent and primary 
irritant contact dermatitis[8]. In association with the 
eradication of the parasite from the skin surface, several 
treatments including topical tea tree oil and oral anti-
parasitic drug such as ivermectin alone or in combination 
with metronidazole are used[9,10]. For the treatment of SD, 
various anti-inflammatory, anti-fungal and keratolytic 
agents have been used individually or in combination, 
which have had different effects on symptoms of SD[11-
19]. In this study in the first step we decided to determine 
the prevalence of SD and AD in patient with Demodex 
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Objective: To determine the prevalence of seborrhoeic dermatitis (SD) and atopic dermatitis (AD) 
between the Demodex folliculorum (D. folliculorum) positive and D. folliculorum negative patients 
and to investigate any possible relationship between the D. folliculorum mites and the presence 
of SD and AD.
Methods: In this cross sectional study, authors collected samples from the skin around the nasal 
tip of 180 randomized patients who reffered to Amir Al-Momenin Hospital dermatology clinic for 
skin erythema, scaling and pruritis, to examine the precence of demodicosis (D. folliculorum) 
infestation under optical microscope. Then authors assessed the prevalence of SD and AD 
between the D. folliculorum positive and D. folliculorum negative patients. Finally, data analysis 
using SPSS software and Chi-square test were performed.
Results: Our study showed no significant association between the demodicosis (D. folliculorum) 
and SD (P=0.68) and AD (P=0.70) prevalence.
Conclusions: According to the result of this study, the eradication of Demodex mites probably 
is not effective to reduces the prevalence of both dermatitis. However further investigation on a 
larger scale in a case-control study in this area is recommended. 
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infestation compared with that of the patient who 
hadn’t Demodex infestation to investigate any possible 
relationship between the Demodex mites and the presence 
of SD and AD.
2. Materials and methods
   The study was conducted between July 2011 and 
September 2012 in dermatology clinic of Amir Al-
Momenin Hospital, Tehran. A total of 180 patients 
without any underlying medical condition with mild 
dermatologic complaints (mild itching or scaling 
or erythema) were recruited and scotch tape skin 
samples were taken with slight pressure on nose 
and cheeks of these patients. We coded the slides 
and examined them within two-three hours by light 
microscopy and evaluated them for the presence 
or absence of Demodex mites. In this study, we 
considered no difference between two species of 
Demodex mites (D. folliculorum, Demodex brevis) 
and we examined each slide for presence of mite 
positivity. Slides without sufficient sebum were 
excluded from the study and none of the cases had 
received any treatment for SD, AD and Demodex 
infestation before.
   Data regarding the age, sex, and previous treatments 
were obtained from the notes. Comparability of Demodex 
positive and Demodex negative patients for sex, age, SD 
and AD was assessed by mean of the Chi-square test. 
3. Results
   In this study of 180 patients, 45% (n=81) of the subjects 
were male and 55% (n=99) were female. Mean age is (27+24.9) 
years, the age range is 14-73 years. 
   In skin samples from patients, 31.7% (n=57) were 
demodicosis negative and 68.3% (123 patients) were 
demodicosis positive.
   About 35% (63 patients) were atopic positive and 65% 
of subjects (n=117) were atopic negative. Chronic and 
relapsing course of pruritis with specific distribution 
area, early age of onset and personal or familial history 
of asthma or hay fever or other atopic diseases were our 
criteria for AD diagnosis.
   About 61.7% (111 subjects) of the subjects were seborrheic 
positive and 38.3% (n=69) were seborrheic negative. The 
skin erythema and pruritis in sebum-rich areas of the scalp, 
face, trunk and scales were our criteria for SD diagnosis. 
Among people with demodicosis (Demodex positive) 46.3% 
were male and 53.7% were women, and in patients without 
demodicosis 42.1% were men and 57.9% were female. There 
was no significant difference between the sex in Demodex 
negative and Demodex positive patients. Also there wasn’t 
a significant correlation between age and demodicosis.
   The prevalence of AD among demodicosis positive 
individuals was 36.6% and in demodicosis negative people 
was 31.6%, which did show no statistically significant 
difference between the two groups in terms of AD 
prevalence.
   The prevalence of SD in demodicosis positive individuals 
was 63.4% and in the demodicosis negative people was 
57.9%, which showed no significant difference between the 
two groups in terms of SD prevalence.
4. Discussion
   This study showed that Demodex mites have no effect on 
the increased prevalence of SD and AD.
   Karincaoglu and his colleagues in Turkey in 2009 
demonstrated that the prevalence of D. folliculorum was 
higher in patients with SD, which is inconsistent with our 
results[6]. This varying result may be due to differences 
in patients’ washing habits, and genetic and ethnic 
differences in Iran and Turkey, or differences in sampling 
techniques, sample size, type of study or may be due to 
other confounding factor. In this paper we use comedo 
extraction band technique for Demodex mites sampling. 
   Bikowski and Del Rosso conducted a research, during 
the years 2006-2008 in America, on 63 patients with 
refractory erythema/rash which was treated experimentally 
by crotamiton 2 times a day for demodicosis, and two visits 
were followed for the relief of rashes[7]. The results showed 
a significant improvement of resistant rashes[7].
   A study in 2010 in America was done on 12 patients with 
refractory chronic blepharoconjunctivitis and at the age 
of 2.5-11 years; the prevalence of Demodex was 100% and 
after one week of treatment with tea tree oil, symptom of 
eye irritation was significantly improved in all patients, 
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and inflammation was also associated with a lower density 
of Demodex[10].
   A study by Emre and his colleagues in turkey in 2009 
demonstrated that D. folliculorum infestation was higher in 
Behcet disease and mite elimination may be useful, even 
in patients without any complaint, for the treatment of 
ocular and eyelid discomforts of these patients[20].
   However, further analytic or experimental investigation 
into the possible role of Demodex mite and its elimination 
effect on the treatment of SD and AD is recommended.
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